发明名称 REMEDIES FOR NEURODEGENERATIVE DISEASES
摘要 Preventive and/or therapeutic drugs for neuro- degenerative diseases including Alzheimer's disease, which contain as the active ingredient substances selected from the group consisting of compounds represented by the general formula (I), pharmacologically acceptable salts thereof, and hydrates and solvates of both: (I) wherein A is hydrogen or acetyl; E is 2,5- or 3,5-disubstituted phenyl or an optionally substituted monocyclic or fused -polycyclic heteroaryl group (exclusive of (1) fused-polycyclic heteroaryl whose benzene ring is bonded directly to the -CONH- group, (2) unsubstituted thiazol-2-yl, and (3) unsubstituted benzothiazol-2-yl); and Z is arene which may have a substituent in addition to the groups represented by the general formulae: -O-A (wherein A is as defined above) and -CONH-E (wherein E is as defined above) or heteroarene which may have a substituent in addition to the groups represented by the general formulae: -O-A (wherein A is as defined above) and -CONH-E (wherein E is as defined above).
申请公布号 WO03103657(A1) 申请公布日期 2003.12.18
申请号 WO2003JP07128 申请日期 2003.06.05
申请人 INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC.;MUTO, SUSUMU;ITAI, AKIKO 发明人 MUTO, SUSUMU;ITAI, AKIKO
分类号 A61K31/167;A61K31/17;A61K31/18;A61K31/235;A61K31/277;A61K31/381;A61K31/40;A61K31/402;A61K31/404;A61K31/415;A61K31/4164;A61K31/42;A61K31/421;A61K31/422;A61K31/426;A61K31/427;A61K31/433;A61K31/437;A61K31/44;A61K31/4406;A61K31/4418;A61K31/445;A61K31/451;A61K31/454;A61K31/47;A61K31/496;A61K31/498;A61K31/505;A61K31/695;(IPC1-7):A61K31/167;A61K31/416;A61K31/440;A61K31/441;A61K31/537 主分类号 A61K31/167
代理机构 代理人
主权项
地址